Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / iovance biotherapeutics amtagvi launch continues upw

IOVA - Iovance Biotherapeutics: Amtagvi Launch Continues Upward

Iovance Biotherapeutics Inc.

2024-06-26 16:55:19 ET

Summary

  • The Amtagvi launch has seen over 100 patients enrolled for therapy since approval, with potential for Q2'24 earnings to reflect some initial sales.
  • IOVA's enrollment of the TILVANCE-301 continues, with updates on enrollment serving as a potential catalyst.
  • Key cohorts of a study of lifileucel in non-small cell lung cancer are set to complete enrollment in 2025.

For further details see:

Iovance Biotherapeutics: Amtagvi Launch Continues Upward
Stock Information
Company Name: Iovance Biotherapeutics Inc.
Stock Symbol: IOVA
Market: NASDAQ
Website: iovance.com
Menu
IOVA IOVA Quote IOVA Short IOVA News IOVA Articles IOVA Message Board
Get IOVA Alerts

News, Short Squeeze, Breakout and More Instantly...